TNFRSF9 and cancer: T cells stably-expressing chimeric antigen receptors (CARs) are also an important adoptive cell therapy product with synthetic immunoreceptors that specifically target cancer cells and contain co-stimulatory receptors such as CD28 or 4-1BB that promote effector cell function, proliferation and persistence33.